Developmental and genetic function of SHROOM3
SHROOM3的发育和遗传功能
基本信息
- 批准号:10587298
- 负责人:
- 金额:$ 53.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:ActomyosinAddressAnimal ModelApicalBindingBiological AssayCause of DeathCell LineageCell PolarityCellsChildCongenital AbnormalityCongenital Heart DefectsCytoskeletonDataDefectDevelopmentDevelopmental BiologyDisease susceptibilityEmbryonic HeartEtiologyExhibitsFamilyFrequenciesGenesGeneticGenetic EpistasisGenetic Predisposition to DiseaseGenomicsHeart AbnormalitiesHeterozygoteHumanHuman GeneticsImmunoprecipitationIn VitroIndianaInvestigationKnowledgeLeadLinkMass Spectrum AnalysisMovementMusMutateMutationOutcomePathway interactionsPatientsPediatric Cardiac Genomics ConsortiumPenetrancePhenocopyPhenotypePredispositionPrognosisProteinsRho-associated kinaseRoleShapesSignal PathwaySignal TransductionTechnologyTestingTissuesTranslatingVariantVentricular Septal DefectsXenopusbiobankcardiogenesiscell motilitycohortcongenital heart disorderconstrictiondevelopmental geneticsdisease phenotypeexomeexome sequencingfunctional genomicsgenetic architecturegenetic testinggenetic variantgenome sequencinggenome wide association studyhuman diseasehuman genomicshuman modelimprovedin vivomembermouse modelnovelplanar cell polarityprotein protein interactionpublic health relevancerare variantrisk predictionsingle-cell RNA sequencingtranscriptome sequencingwhole genome
项目摘要
PROJECT SUMMARY
Congenital heart disease (CHD) is the most common cause of death due to birth defects. Despite its frequency,
identifying genetic causes of CHD has been challenging. Mendelian inheritance of sporadic (nonsyndromic) CHD
is rare. Instead, the genetic architecture of CHD is characterized by non-penetrance, variable expressivity, and
likely oligogenic effects. Although genome wide association studies, trio, and family-based studies have been
utilized, there has been little emphasis on examining epistasis, additive effects, or mutational burden.
Furthermore, although an improved understanding of cardiac development has identified genes and pathways
that underlie CHD in animal models, this knowledge has not always translated readily into an understanding of
disease causation in human CHD. In order to improve our ability to predict risk for CHD and prognosis, it is
important to identify new genes and pathways that contribute to sporadic CHD and integrate functional genomics
for variant analysis with developmental biology for mechanistic understanding. We propose to address these
critical needs through investigation of a novel gene causing cardiac malformations, SHROOM3, and delineation
of its interactome, as an exemplar leveraging human genomics and developmental biology. The aims of this
study are to: 1) test the hypothesis that cardiogenesis requires SHROOM3 interaction with planar cell polarity
(PCP) proteins and downstream effectors. The outcome of this aim will identify cell- and tissue-specific
consequences of loss of Shroom3, identify its interactome and consequence of its genetic interactions on CHD;
and 2) test the hypothesis that rare variants in genes encoding PCP signaling and downstream effector proteins
are enriched in patients with CHD. The outcome of this aim will functionally validate SHROOM3 rare variants
and identify genes and pathways important for the susceptibility to CHD. Using a combination of functional
genomics to define the impact of rare variants, mechanistic studies using mouse models, and human genetics,
these studies will collectively define the role of SHROOM3 in heart development and the contribution of
SHROOM3 and PCP pathway members to the genetic architecture of CHD.
项目概要
先天性心脏病(CHD)是出生缺陷导致的最常见死亡原因。尽管其频率很高,
确定冠心病的遗传原因一直具有挑战性。散发性(非综合征性)先心病的孟德尔遗传
是罕见的。相反,先心病的遗传结构具有非外显性、可变表达性和
可能的寡基因效应。尽管全基因组关联研究、三重奏和基于家族的研究已
使用时,很少强调检查上位性、附加效应或突变负担。
此外,尽管对心脏发育的了解有所提高,已经确定了基因和途径
尽管这些知识是动物模型中先心病的基础,但这些知识并不总是能轻易转化为对
人类冠心病的致病原因。为了提高我们预测冠心病风险和预后的能力,
识别导致散发性冠心病的新基因和途径并整合功能基因组学非常重要
通过发育生物学进行变异分析,以实现机制理解。我们建议解决这些问题
通过研究导致心脏畸形的新基因 SHROOM3 和轮廓来满足关键需求
其相互作用组,作为利用人类基因组学和发育生物学的范例。本次活动的目的
研究目的是:1)检验心脏发生需要 SHROOM3 与平面细胞极性相互作用的假设
(PCP) 蛋白和下游效应子。这一目标的结果将确定细胞和组织特异性
Shroom3 缺失的后果,确定其相互作用组及其遗传相互作用对 CHD 的影响;
2) 检验编码 PCP 信号和下游效应蛋白的基因中存在罕见变异的假设
CHD 患者体内含量丰富。这一目标的结果将在功能上验证 SHROOM3 罕见变体
并确定对冠心病易感性重要的基因和途径。使用功能组合
基因组学来定义罕见变异的影响,使用小鼠模型进行机制研究,以及人类遗传学,
这些研究将共同定义 SHROOM3 在心脏发育中的作用以及
CHD 遗传结构的 SHROOM3 和 PCP 通路成员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephanie M Ware其他文献
Approaches to Studying Outcomes in Patients With Congenital Heart Disease With Genetic Syndromes: What Down Syndrome Can Teach Us
研究患有遗传综合症的先天性心脏病患者的结果的方法:唐氏综合症可以教会我们什么
- DOI:
10.1161/jaha.123.033193 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Stephanie M Ware - 通讯作者:
Stephanie M Ware
4 – Adults With Congenital Heart Disease: A Genetic Perspective
4 – 患有先天性心脏病的成年人:遗传学视角
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
W. A. Kay;Stephanie M Ware - 通讯作者:
Stephanie M Ware
Stephanie M Ware的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephanie M Ware', 18)}}的其他基金
Left-right patterning abnormalities and cardiac morphogenesis
左右模式异常和心脏形态发生
- 批准号:
9208534 - 财政年份:2017
- 资助金额:
$ 53.09万 - 项目类别:
The role of ZIC3 within cardiomyocyte precursors in cardiac morphogenesis
ZIC3 在心肌细胞前体细胞中在心脏形态发生中的作用
- 批准号:
10495949 - 财政年份:2017
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
7837549 - 财政年份:2009
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
7588010 - 财政年份:2007
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
8056809 - 财政年份:2007
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
7249754 - 财政年份:2007
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
7386696 - 财政年份:2007
- 资助金额:
$ 53.09万 - 项目类别:
Role of the Embryonic Node in Cardiac Development and Congenital Heart Disease
胚胎节点在心脏发育和先天性心脏病中的作用
- 批准号:
7781379 - 财政年份:2007
- 资助金额:
$ 53.09万 - 项目类别:
Zic3 and the Control of Body Pattern Formation
Zic3 和身体模式形成的控制
- 批准号:
6322902 - 财政年份:2001
- 资助金额:
$ 53.09万 - 项目类别:
Zic3 and the Control of Body Pattern Formation
Zic3 和身体模式形成的控制
- 批准号:
6528008 - 财政年份:2001
- 资助金额:
$ 53.09万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Molecular and Cell Biological Foundations of Proteostress-Induced Neuronal Extrusion
蛋白质应激诱导的神经元挤压的分子和细胞生物学基础
- 批准号:
10753902 - 财政年份:2023
- 资助金额:
$ 53.09万 - 项目类别:
Influence of hemodynamic shear stress on circulating tumor cells
血流动力学剪切应力对循环肿瘤细胞的影响
- 批准号:
10442218 - 财政年份:2022
- 资助金额:
$ 53.09万 - 项目类别:
Sustained Delivery of RhoA activator for Treatment of Intervertebral Disc Degeneration
持续递送 RhoA 激活剂治疗椎间盘退变
- 批准号:
10391978 - 财政年份:2022
- 资助金额:
$ 53.09万 - 项目类别:
Sustained Delivery of RhoA activator for Treatment of Intervertebral Disc Degeneration
持续递送 RhoA 激活剂治疗椎间盘退变
- 批准号:
10661491 - 财政年份:2022
- 资助金额:
$ 53.09万 - 项目类别:
Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation
非常规肌球蛋白以及炎症期间肠道屏障完整性和恢复的调节
- 批准号:
10443882 - 财政年份:2020
- 资助金额:
$ 53.09万 - 项目类别: